The law firm of Wohl & Fruchter LLP is investigating possible violations
of federal securities laws by officers and directors of STAAR Surgical
Company (STAAR) (Nasdaq: STAA).
On July 1, 2014, the U.S. Food and Drug Administration (FDA) released a
copy of a warning letter (FDA Warning Letter) issued to STAAR on May 21,
2014 indicating that various methods used at STAAR's Monrovia,
California facility do not conform with good manufacturing practices as
required under applicable federal regulations. The FDA Warning Letter
identified at least fifteen (15) violations to which the Company had not
yet provided an adequate response.
On the above news, STAA shares have fallen over 17% in trading since
July 1, 2014.
Persons with relevant information, and STAA shareholders with questions
about this investigation, are invited to contact the attorney below, or
our Firm y calling 866.833.6245.
Additional information, including a copy of the FDA Warning Letter, is
available on our website at: http://www.wohlfruchter.com/cases/staa.
About Wohl & Fruchter
Wohl & Fruchter LLP represents plaintiffs in litigation arising from
fraud and other fiduciary breaches by corporate managers, as well as
other complex litigation matters. Please visit our website, www.wohlfruchter.com,
to learn more about our Firm, or contact one of our partners.
J. Elazar Fruchter (email@example.com)845.425.4658
or Toll Free 866.833.6245Wohl & Fruchter LLP570
Lexington AvenueNew York, NY 10022www.wohlfruchter.com
This release may be deemed to constitute attorney advertising.
[ Back To NFVZone's Homepage ]